Drug Utilization Review Board Meeting

1. Call to Order.
2. Approval of Minutes from January 29, 2015 Drug Utilization Review (DUR) Board Meeting. (Vote Required)
3. Hepatitis C Drugs Update:  Josh Dominguez, Pharm. D. (Vendor Drug Program).
4. Report of Recent Retrospective DUR Interventions:  Larry Dent, Pharm. D., BCPS (Xerox Heritage, LLC).
   1. Drugs with Abuse Potential.
   2. Medication Adherence.
   3. Non-steroidal Anti-inflammatory Drugs.
5. Reports on Recent Retrospective DUR Proposals:  Larry Dent, Pharm. D., BCPS, (Xerox Heritage, LLC).
   1. Chronic Non-Malignant Pain
   2. Gastrointestinal Agents Drug Use Evaluation
   3. Depression Management
6. Retrospective DUR Proposals:  Larry Dent, Pharm D, BCPS, (Xerox Heritage, LLC). (Vote Required).*
   1. Atypical Antipsychotics: Optimization of Use.
   2. Diabetes Disease Management.
7. Prospective Prior Authorization Proposals (Clinical Edits): Christine Faulkner, PharmD. (Health Information Designs, LLC). (Vote Required).*
   1. Cough and Cold.
   2. Leukotriene Modifiers.
8. Retrospective Drug Use Criteria for Outpatient Use in the Vendor Drug Program: Jennifer Seltzer, PharmD. (University of Texas San Antonio). (Vote required).*
   1. Antidepressant Drugs.
   2. Attention Deficit Disorder/Hyperactivity Disorder Medications.
   3. Parenteral Enzyme or Protein Replacement Therapy.
   4. Histamine H2-Receptor Antagonists.
   5. Low-Molecular-Weight Heparins.
   6. Proton Pump Inhibitors.
9. Next Meeting Date:  Thursday, July 23, 2015.
10. Adjourn.

*Public comment will be taken on this agenda item.

 

VISIT US AT GARLO WARD, PC